
Sign up to save your podcasts
Or


Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors' response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.
By American Academy of Neurology4.7
1919 ratings
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors' response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.

137 Listeners

323 Listeners

499 Listeners

296 Listeners

49 Listeners

13 Listeners

192 Listeners

93 Listeners

514 Listeners

136 Listeners

368 Listeners

190 Listeners

375 Listeners

6 Listeners

83 Listeners